Ranjeet Banerjee is an extremely successful and experienced medical technology executive who has spent the last 25 years with Becton Dickinson (“BD”), a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. Most recently, he was a BD Corporate Executive Vice President as well as President of the US and Canada regions with responsibility for $6 billion in revenue. Over his career at BD, Ranjeet has been responsible for growing businesses in the Americas, Europe, and Asia, pioneering new business models, and developing innovative product and service offerings to deliver a differentiated experience to BD’s customers. Ranjeet earned a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology and brings a wealth of experience in growing branded, medical-oriented, high-technology businesses both organically and through acquisition.

The last mile of the Life Sciences value chain is crucially important when transporting drugs, vaccines, and biologics that must remain within controlled conditions (temperature, humidity, etc.). Poor conditions and even small excursions can significantly impact the quality and efficacy of the products. Building the right strategy for the last mile should never be an afterthought!  It was shocking to learn that an estimated $40-50B is lost annually due to inefficiencies and poor conditions that lead to waste (=products being discarded)!

As Ranjeet noted, "the pace of technology and innovation is often faster than the pace of collaboration".  To stop the waste, no one company can "do it alone".  Listen to Ranjeet describe what it would take to build a game-changing strategy and path to stop the waste and truly advance life sciences value chain innovation.